JPRN-UMIN000036007
Completed
未知
The therapy of basic fibroblast growth factor (bFGF) for perianal abscess and postoperative surgical site infection - The therapy of bFGF
iigata University Dental and Medical Hospital0 sites0 target enrollmentMarch 1, 2019
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Perianal abscess and Surgical site infection
- Sponsor
- iigata University Dental and Medical Hospital
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •When suffer severe adverse event on children
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of basic fibroblast growth factor (bFGF) in combination with natural bone mineral on periodontal regeneratioPeriodontitisJPRN-UMIN000025257Department of Periodontology, Tokyo Dental College44
Completed
Phase 1
Fibroblast growth factor receptors (FGFR) Inhibition for Epithelial Solid TumoursEpithelial Solid TumoursCancerEpithelial tumourISRCTN44149443niversity of Leeds (UK)28
Completed
Phase 2
Phase II study with oral fibroblast growth factor-1 inhibitor BIBF1120 as treatment in lung carcinoma patients harboring fibroblast growth factor receptor-1 gene amplification (NVALT-15 study)NL-OMON44999Stichting NVALT studies40
Active, not recruiting
Phase 1
Study with BIBF1120 in lung canger patients with an abnormal fibroblast growth factor-1 receptor (NVALT-15 study)on small cell lung cancerMedDRA version: 20.0Level: PTClassification code 10029522Term: Non-small cell lung cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10029521Term: Non-small cell lung cancer stage IIIBSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2013-004324-11-NLStichting NVALT studies76
Active, not recruiting
Phase 1
Study with BIBF1120 in lung canger patients with an abnormal fibroblast growth factor-1 receptor (NVALT-15 study)on small cell lung cancerMedDRA version: 17.1 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.1 Level: PT Classification code 10029521 Term: Non-small cell lung cancer stage IIIB System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2013-004324-11-ESStichting NVALT studies80